State-of-the-art biosimilar erythropoietins in the management of renal anemia: lessons learned from Europe and implications for US nephrologists
Crossref DOI link: https://doi.org/10.1007/s11255-015-1042-9
Published Online: 2015-07-30
Published Print: 2015-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Covic, Adrian
Abraham, Ivo
Text and Data Mining valid from 2015-07-30